Objective: To determine the effect of flurbiprofen combined with prednisolone on interleukin-6 in elderly surgery patients. Methods: In this double-blind randomized controlled study, patients aged 65 to 80 who we...Objective: To determine the effect of flurbiprofen combined with prednisolone on interleukin-6 in elderly surgery patients. Methods: In this double-blind randomized controlled study, patients aged 65 to 80 who were undergoing spinal fusion surgery for disc herniation were administered flurbiprofen 100 mg (P group, flurbiprofen group), prednisolone 0.6 mg/kg (D group, prednisolone group), prednisolone 0.6 mg/kg plus flurbiprofen 100 mg (P + D group, flurbiprofen + prednisolone group) or normal saline (S group, saline group) 15 minutes before the induction of anesthesia. Plasma samples were collected before surgery (T0) and on day 1 (T1), day 2 (T2) and day 3 (T3) following surgery. At the same time, systemic inflammatory response syndrome (SIRS) was assessed by SIRS criteria. The levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP) for collected samples were measured. Results: Other groups had significantly lower levels of IL-6, CRP and occurrence of SIRS than S group (p < 0.05). Compared to groups P and D, the levels of IL-6 and CRP in P + D group were significantly lower on T1 (p < 0.05). Peak levels of IL-6 in all groups were presented on T1 (p 0.05). The levels of CRP within three days were significantly different but did not show peak levels (p > 0.05). Conclusion: Compared to prednisolone or flurbiprofen, combining flurbiprofen with prednisolone in elderly surgery patients led to an increased suppression of IL-6.展开更多
文摘目的探讨芪地补肾方对糖尿病肾病患者肾功能及血清白介素6(interleukin-6,IL-6)、肿瘤坏死因子α(tumor necrosis factorα,TNF-α)、分泌型卷曲蛋白4(secreted frizzled-related protein-4,SFRP-4)的影响。方法将93例糖尿病肾病患者分为观察组47例和对照组46例。对照组脱落1例,剩余45例患者给予常规基础治疗,口服厄贝沙坦片。观察组脱落2例,剩余45例患者在对照组基础上,联合芪地固肾汤治疗。比较两组治疗3个月的总有效率。检测两组治疗前后空腹血糖、餐后2小时血糖、肾小球滤过率(glomerular filtration rate,GFR)、胱抑素C(cystatin C,Cys-C)、IL-6、TNF-α、SFRP-4的水平。运用糖尿病生存质量特异性量表(diabetes specific quality of life scale,DSQL)评估患者的生活质量。结果观察组治疗3个月的总有效率为95.56%,对照组为80.00%,经统计学比较,差异有显著性(P<0.05)。治疗后,两组的血糖指标显著降低(P<0.05);观察组治疗后的血糖指标低于对照组,经统计学比较,差异有统计学意义(P<0.05)。两组治疗后的GFR、β2-微球蛋白、Cys-C明显低于治疗前,且观察组的GFR、β2-微球蛋白、Cys-C低于对照组,经统计学比较,差异有显著性(P<0.05)。两组治疗后的IL-6、TNF-α、SFRP-4低于治疗前,(P<0.05);观察组的IL-6、TNF-α、SFRP-4低于对照组,经统计学比较,差异有统计学意义(P<0.05)。两组治疗后的DSQL各项评分显著降低,且观察组较对照组降低更明显,经统计学比较,差异有显著性(P<0.05)。结论芪地补肾方能提高糖尿病肾病的疗效,可进一步改善患者肾功能和降低血糖,减轻炎症反应,提高患者的生活质量。
文摘Objective: To determine the effect of flurbiprofen combined with prednisolone on interleukin-6 in elderly surgery patients. Methods: In this double-blind randomized controlled study, patients aged 65 to 80 who were undergoing spinal fusion surgery for disc herniation were administered flurbiprofen 100 mg (P group, flurbiprofen group), prednisolone 0.6 mg/kg (D group, prednisolone group), prednisolone 0.6 mg/kg plus flurbiprofen 100 mg (P + D group, flurbiprofen + prednisolone group) or normal saline (S group, saline group) 15 minutes before the induction of anesthesia. Plasma samples were collected before surgery (T0) and on day 1 (T1), day 2 (T2) and day 3 (T3) following surgery. At the same time, systemic inflammatory response syndrome (SIRS) was assessed by SIRS criteria. The levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP) for collected samples were measured. Results: Other groups had significantly lower levels of IL-6, CRP and occurrence of SIRS than S group (p < 0.05). Compared to groups P and D, the levels of IL-6 and CRP in P + D group were significantly lower on T1 (p < 0.05). Peak levels of IL-6 in all groups were presented on T1 (p 0.05). The levels of CRP within three days were significantly different but did not show peak levels (p > 0.05). Conclusion: Compared to prednisolone or flurbiprofen, combining flurbiprofen with prednisolone in elderly surgery patients led to an increased suppression of IL-6.
基金江苏省科技支撑计划(BE2012310)Financially Supported by Special Foundation for Clinical Studies from Committee of Medical Journal of Chinese Universities(11221022)
